Compounds > adamantane

Page last updated: 2024-08-21

adamantane and Pemphigoid, Bullous

adamantane has been researched along with Pemphigoid, Bullous in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	8 (80.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Cranwell, WC; Gin, D; Goh, MS; Lim, SS; McLean, CA	1
Cheng, CY; Chiang, CP; Chien, WC; Chung, CH; Hung, CT; Liu, JS; Wang, WM	1
Abeni, D; Collina, MC; Di Zenzo, G; Didona, B; Fania, L; Mazzanti, C; Pagnanelli, G; Provini, A; Salemme, A	1
Borradori, L; Buclin, T; Cazzaniga, S; Feldmeyer, L; Gilliet, M; Jornayvaz, FR; Schaffer, C	1
España, A; García-Díez, I; Hashimoto, T; Herrero-Gonzalez, JE; Iranzo, P; Ishii, N; Ivars-Lleó, M; López-Aventín, D; Pujol, RM	1
Aouidad, I; Crickx, B; Descamps, V; Deschamps, L; Fite, C; Marinho, E	1
Auffret, M; Babai, S; Béné, J; Coupe, P; Gautier, S; Hillaire-Buys, D; Jacobsoone, A; Jean-Pastor, MJ; Tronquoy, AF; Vermersch, A; Vonarx, M	1
Camacho-Martinez, F; Martín-Gutierrez, FJ; Mendonça, FM; Ríos-Martín, JJ	1
Ersoy-Evans, S; Gököz, O; Gönül, M; Keseroglu, HO; Taş-Aygar, G	1

Reviews

1 review(s) available for adamantane and Pemphigoid, Bullous

Article	Year
Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin. Dermatology (Basel, Switzerland), 2016, Volume: 232, Issue:2 Topics: Adamantane; Aged; Aged, 80 and over; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Female; Humans; Linagliptin; Male; Nitriles; Pemphigoid, Bullous; Pyrrolidines; Vildagliptin	2016

Other Studies

9 other study(ies) available for adamantane and Pemphigoid, Bullous

Article	Year
Bullous pemphigoid secondary to saxagliptin mimicking toxic epidermal necrolysis. The Australasian journal of dermatology, 2022, Volume: 63, Issue:1 Topics: Adamantane; Autoantibodies; Autoimmune Diseases; Diagnosis, Differential; Dipeptides; Humans; Pemphigoid, Bullous; Stevens-Johnson Syndrome	2022
Increased risk of bullous pemphigoid in dipeptidyl peptidase 4 inhibitors: A nationwide, population-based, cohort study in Taiwan. The Journal of dermatology, 2020, Volume: 47, Issue:3 Topics: Adamantane; Adult; Age Factors; Aged; Case-Control Studies; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Incidence; Linagliptin; Male; Middle Aged; Pemphigoid, Bullous; Piperidines; Risk Factors; Sitagliptin Phosphate; Taiwan; Uracil; Vildagliptin; Young Adult	2020
Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: Adamantane; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Collagen Type XVII; Dipeptidyl-Peptidase IV Inhibitors; Epitopes; Female; Humans; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Linagliptin; Male; Membrane Glycoproteins; Middle Aged; Nitriles; Non-Fibrillar Collagens; Pemphigoid, Bullous; Piperidines; Pyrrolidines; Sitagliptin Phosphate; Uracil; Vildagliptin	2018
Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid. Dermatology (Basel, Switzerland), 2017, Volume: 233, Issue:5 Topics: Adamantane; Aged; Aged, 80 and over; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Pemphigoid, Bullous; Pyrrolidines	2017
Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization. International journal of dermatology, 2018, Volume: 57, Issue:7 Topics: Adamantane; Aged; Aged, 80 and over; Autoantigens; Collagen Type XVII; Dipeptidyl-Peptidase IV Inhibitors; Dystonin; Female; Humans; Immunoglobulin G; Linagliptin; Male; Nitriles; Non-Fibrillar Collagens; Pemphigoid, Bullous; Phenotype; Pyrrolidines; Sitagliptin Phosphate; Vildagliptin	2018
A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. JAMA dermatology, 2013, Volume: 149, Issue:2 Topics: Adamantane; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Male; Middle Aged; Nitriles; Pemphigoid, Bullous; Pyrrolidines; Severity of Illness Index; Vildagliptin	2013
Bullous pemphigoid induced by vildagliptin: a report of three cases. Fundamental & clinical pharmacology, 2015, Volume: 29, Issue:1 Topics: Adamantane; Aged; Aged, 80 and over; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Nitriles; Pemphigoid, Bullous; Pyrrolidines; Vildagliptin	2015
Gliptins: bullous pemphigoid. Prescrire international, 2015, Volume: 24, Issue:158 Topics: Adamantane; Aged; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Male; Nitriles; Pemphigoid, Bullous; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin	2015
A case of bullous pemphigoid ınduced by vildagliptin. Cutaneous and ocular toxicology, 2017, Volume: 36, Issue:2 Topics: Adamantane; Administration, Cutaneous; Clobetasol; Complement C3; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Female; Fluorescent Antibody Technique; Gliclazide; Glucocorticoids; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Nitriles; Pemphigoid, Bullous; Pyrrolidines; Skin; Vildagliptin; Withholding Treatment	2017